Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfc40f659da1d992b110e511eeac9dd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b104f44b4bcb2d45f3ddbcb96339fbfd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf5550417b6e78f71a72b2b48c802900 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c6462bbd53eba88febbb299648cd21f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6e92268dd826758f96bd9233383f320 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1214 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 |
filingDate |
2004-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b55307735cdc3544b2758292efb8bcd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8974facf9fb5b34ae7e0613b86b2eb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81b4ef325bb6600ac1cadf6cdc862a99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a562ca49e3029f4c441391fe56faf857 |
publicationDate |
2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004099250-A1 |
titleOfInvention |
Peptide compositions and methods of producing and using same |
abstract |
Peptide compositions and methods of producing and using same are provided. The peptide compositions are based on pilin peptides derived from Pseudomonas aeruginosa. The compositions include antigens and antibodies immunoreactive against the antigens. The compositions can be utilized in vaccines for treatment purposes, such as to treat or prevent infection associated with Pseudomonas aeruginosa and/or other infectious agents. Further, the compositions can be utilized to produce antibody or monoclonal antibody therapeutic to treat or prevent infection associated with Pseudomonas aeruginosa and/or other infectious agents. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9085611-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2248826-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2248826-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8518415-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009081955-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010135585-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2599792-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007049770-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9310381-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007114340-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501179-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9802988-B2 |
priorityDate |
2003-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |